Sale!

EIF2B3 Gene Leukoencephalopathy with vanishing white matter Genetic Test

4,400 د.إ

-21%

The EIF2B3 gene plays a crucial role in the normal functioning of the brain, and mutations in this gene can lead to a rare condition known as Leukoencephalopathy with vanishing white matter (VWM). This neurological disorder is characterized by a progressive deterioration of white matter in the brain, leading to symptoms such as spasticity, ataxia, and cognitive decline. VWM can manifest at any age, but it most commonly appears in childhood.

To diagnose this condition, a genetic test targeting the EIF2B3 gene can be conducted. DNA Labs UAE offers this specific test, providing a valuable tool for individuals and families seeking answers about this debilitating condition. The test involves analyzing the DNA to detect mutations in the EIF2B3 gene that are indicative of VWM. This genetic test is priced at 4400 AED and is a critical step towards confirming the diagnosis, which can then guide treatment and management strategies for affected individuals. Early diagnosis through this genetic testing can also aid in the understanding of the disease’s progression and potential outcomes, enabling better planning and support for those affected and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EIF2B3 Gene Leukoencephalopathy with vanishing white matter Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for EIF2B3 Gene Leukoencephalopathy with vanishing white matter NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EIF2B3 Gene Leukoencephalopathy with vanishing white matter.

Test Details

The EIF2B3 gene is associated with a rare genetic disorder called leukoencephalopathy with vanishing white matter (VWM). This disorder affects the central nervous system, particularly the white matter of the brain.

A next-generation sequencing (NGS) genetic test for the EIF2B3 gene can be used to identify mutations or variations in this gene that may be responsible for VWM. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire exome (the protein-coding regions of the genome).

By analyzing the EIF2B3 gene using NGS, healthcare professionals can determine if a patient carries any pathogenic or disease-causing variants in this gene. This information can be crucial for diagnosing VWM and providing appropriate genetic counseling to affected individuals and their families.

It is important to note that genetic testing for VWM is typically recommended for individuals with symptoms suggestive of the disorder, such as progressive neurological deterioration, ataxia, spasticity, or seizures. Genetic testing is not typically performed as a routine screening test.

If you suspect that you or someone you know may have VWM or are at risk for carrying pathogenic variants in the EIF2B3 gene, it is recommended to consult with a healthcare professional or a genetic counselor who can guide you through the testing process and provide appropriate guidance and support.

Test Name EIF2B3 Gene Leukoencephalopathy with vanishing white matter Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EIF2B3 Gene Leukoencephalopathy with vanishing white matter NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EIF2B3 Gene Leukoencephalopathy with vanishing white matter
Test Details

The EIF2B3 gene is associated with a rare genetic disorder called leukoencephalopathy with vanishing white matter (VWM). This disorder affects the central nervous system, particularly the white matter of the brain.

A next-generation sequencing (NGS) genetic test for the EIF2B3 gene can be used to identify mutations or variations in this gene that may be responsible for VWM. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire exome (the protein-coding regions of the genome).

By analyzing the EIF2B3 gene using NGS, healthcare professionals can determine if a patient carries any pathogenic or disease-causing variants in this gene. This information can be crucial for diagnosing VWM and providing appropriate genetic counseling to affected individuals and their families.

It is important to note that genetic testing for VWM is typically recommended for individuals with symptoms suggestive of the disorder, such as progressive neurological deterioration, ataxia, spasticity, or seizures. Genetic testing is not typically performed as a routine screening test.

If you suspect that you or someone you know may have VWM or are at risk for carrying pathogenic variants in the EIF2B3 gene, it is recommended to consult with a healthcare professional or a genetic counselor who can guide you through the testing process and provide appropriate guidance and support.